Psoriasis

The AJMC® Psoriasis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin disease, which tends to go through cycles where it flares and goes into remission.

Latest News

Pediatric Psoriasis | Image Credit: Evgeniya Primavera - stock.adobe.com .jpeg
Review Reveals the Hidden Burden of Psoriasis on Children, Families

September 15th 2025

A new study highlights the epidemiological, humanistic, and economic impact of pediatric psoriasis, with findings showing greater challenges in moderate to severe cases.

Person reading on phone | Image credit: Farknot Architect - stock.adobe.com
Opportunities, Challenges in Digital Media and Psoriasis

September 10th 2025

Doctor examines patient with psoriasis rash | ARTFULLY-79 - stock.adobe.com
Real-World Data Show 12-Month Drug Survival Rates Among Anti-TNF Biosimilars in Psoriasis, PsA

September 8th 2025

Adalimumab | Image credit: luchschenF - stock.adobe.com
Infection Risk Higher in HS Compared With Psoriasis With Adalimumab

September 2nd 2025

Psoriatic arthritis | Image credit: Oporty786 - stock.adobe.com
The Totality of Evidence of Ustekinumab Biosimilar SB17

September 1st 2025

A Personalized Approach to Disease Management in Psoriasis

A panel of experts discuss their personalized approaches to treating patients with psoriasis and comorbidities such as metabolic syndrome.

Ryan Haumschild, PharmD, MS, MBA, Bhavesh Shah, PharmD, Mark Lebwohl, MD, and Robert Groves, MD.
Continuing Medical Education
View All
September 16th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
September 16th 2025

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape for Managed Care Professionals

August 19, 2025 | 1:00 PM & 8:00 PM ET
September 16th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Physician speaking with patient.
October 9th 2021

Evaluating Common Conditions That Precede Psoriatic Arthritis Diagnosis

Matthew Gavidia
Patients with psoriatic arthritis (PsA) were found to be more likely to report musculoskeletal symptoms and dermatologic issues prior to initial PsA diagnosis.
Physician checking patient's hand.
October 6th 2021

Brodalumab May Enhance Skin Clearance, QOL vs Ustekinumab for Psoriasis

Matthew Gavidia
Patients with moderate to severe psoriasis were shown to achieve and maintain higher levels of complete skin clearance and quality of life when treated with brodalumab vs ustekinumab, regardless of the presence of lifestyle risk factors.
Patient and physician.
October 1st 2021

High Rate of Secukinumab Retention Shown Long Term in Patients With Psoriasis

Matthew Gavidia
Secukinumab was associated with a high rate of short- and long-term drug survival in the treatment of patients with psoriasis, with factors such as obesity and prior biologic use linked to discontinuation of use.
Physician and patient.
September 29th 2021

Positive Fecal Immunochemistry Test May Increase Risk of Psoriasis

Matthew Gavidia
Patients with a positive fecal immunochemistry test (FIT) were shown to be at significantly greater risk of developing psoriasis than those with FIT-negative tests.
Person smoking a cigarette.
September 25th 2021

Smoking, Periodontitis Linked With Increased Risk of Psoriasis

Matthew Gavidia
Patients with periodontitis had a potential increased risk of developing psoriasis, particularly those who smoked.
Measurement tapes.
September 22nd 2021

Body Surface Area May Predict Risk of Psoriatic Arthritis in Patients With Psoriasis

Matthew Gavidia
Greater body surface area was shown to correlate with an increased risk of psoriatic arthritis development in patients with psoriasis, with obesity and depression also identified as risk factors.
Person touching skin on their back.
September 18th 2021

Guselkumab Associated With Improved HRQOL, Skin Manifestations in Patients With Psoriasis

Matthew Gavidia
Treatment of guselkumab was found to be safe and effective in improving health-related quality-of-life (HRQOL) and skin manifestations of patients with moderate to severe psoriasis in a real-world setting.
Stethoscope on dollar bills (health care cost).
September 15th 2021

High OOP Costs for Treatment of Psoriatic Disease Found in Medicare Beneficiaries

Matthew Gavidia
Medicare beneficiaries with psoriasis and psoriatic arthritis were found to pay high annual out-of-pocket (OOP) costs for treatment, which researchers attributed to rising drug prices and reliance on co-insurance for patient cost-sharing.
Diabetes stock photo.
September 11th 2021

Alpha-Glucosidase Inhibitor Use in Type 2 Diabetes Linked With Increased Psoriatic Disease Risk

Matthew Gavidia
Discontinued use and high dosage of alpha-glucosidase inhibitors in combination with metformin was shown to increase risk of psoriasis and psoriatic arthritis in patients with type 2 diabetes compared with those given only metformin.
Physician checking joint swelling of patient.
September 9th 2021

Phase 2 Study Finds Tildrakizumab Effective for PsA Manifestations

Matthew Gavidia
Findings of a phase 2b study indicated that use of tildrakizumab was associated with significant improvements in joint and skin manifestations of patients with psoriatic arthritis (PsA), although improvement in symptoms of dactylitis and enthesitis were not observed.
Computer graphic of body and medication
September 1st 2021

Depression, Lack of Efficacy Linked With DMARD Discontinuation in PsA

Jared Kaltwasser
By year 5 of therapy with disease-modifying anti-rheumatic drugs (DMARDs), only about one-third of patients with psoriatic arthritis (PsA) were expected to be continuing with their therapy.
Reverberating pain in a person's hands.
August 26th 2021

Biologic Use May Decrease Risk of Psoriatic Arthritis in Patients With Psoriasis

Matthew Gavidia
Patients with psoriasis who received biologic treatments were at significantly lower risk of developing psoriatic arthritis, with women representing a potentially at-risk group.
Woman exercising.
August 18th 2021

Physical Activity May Lower Risk of Cardiovascular Disease in Patients With Psoriasis

Matthew Gavidia
Physical activity was significantly associated with cardiorespiratory fitness and pulse wave velocity, a preclinical indicator of future cardiovascular disease risk, in patients with psoriasis.
Psoriasis Linked With Severe Coronary Calcification, Heart Disease
August 15th 2021

Psoriasis Linked With Severe Coronary Calcification, Heart Disease

Jared Kaltwasser
A recent study aimed to understand whether psoriasis and psoriatic arthritis are independent risk factors for coronary calcification and coronary artery disease. It found both correlate with higher rates of calcification, but only psoriasis was linked with severe calcification and disease.
White pills on blue background
August 10th 2021

Study: Psoriatic Arthritis, Joint Pain Drive Analgesic Use in Patients With Psoriasis

Jared Kaltwasser
A new prospective cohort study suggests joint pain, rather than skin pain or disease severity, correlates with greater use of analgesics.
Psoriasis patch on hand.
August 6th 2021

Analysis Finds Elevated Risk of Psoriasis, Psoriatic Arthritis in Patients With Uveitis

Matthew Gavidia
Taiwanese patients with uveitis were shown to be at greater risk of developing psoriasis and psoriatic arthritis than the general population, and hypertension, diabetes, and obesity were more prominent in these populations as well.
Person measuring body fat.
July 29th 2021

Obesity Linked With Lower QOL, Greater Disease Burden in Patients With Psoriatic Arthritis

Matthew Gavidia
Patients with psoriatic arthritis and rheumatoid arthritis who were obese were shown to present with significantly lower quality of life (QOL) and worse disease activity than those with normal weight.
Hospital floor setting.
July 21st 2021

Infliximab, Adalimumab Use Associated With Risk of Serious Infection in Patients With Psoriasis

Matthew Gavidia
New users of infliximab and adalimumab who had moderate to severe psoriasis exhibited an increased risk of hospitalization due to serious infection compared with etanercept users, with use of ustekinumab conversely linked with a decreased risk.
files on shelf
July 17th 2021

Assessing Performance of Psoriasis, Atopic Dermatitis Questionnaires Over Time

Gianna Melillo
Researchers investigated whether responses to questionnaires on psoriasis and atopic dermatitis prevalence remained consistent over time.
Young adults.
July 15th 2021

Low Fitness in Young Adults May Increase Risk of Psoriasis Later in Life

Matthew Gavidia
Low cardiorespiratory fitness among young adult men was significantly associated with an increased risk of psoriasis and psoriatic arthritis over 3 decades.
blood vessel
July 10th 2021

Patients With Psoriatic Arthritis Have Altered Hemostatic Function, Analysis Finds

Jared Kaltwasser
The new report may help explain why patients with psoriasis have a higher risk of cardiovascular problems.
Psoriasis One of the Most Common Immune-Mediated Diseases Affecting US Adults
July 8th 2021

Psoriasis One of the Most Common Immune-Mediated Diseases Affecting US Adults

Lauren Massaro
Psoriasis is prevalent among more than 7.5 million adults in the United States, a new study says.
Hand with psoriasis
June 29th 2021

Case Reports: Off-label Tildrakizumab Effective in Nail Psoriasis

Jared Kaltwasser
A new report suggests patients with persistent nail psoriasis may benefit from biologics like tildrakizumab.
man with dry itchy skin scratching his hand
June 26th 2021

Psoriasis Recap: Updated COVID-19 Guidance, Guselkumab Study Results, and More

Skylar Jeremias
Recent reports document new COVID-19 guidance for people with psoriatic disease, positive safety and efficacy results for guselkumab, and findings linking the C-Jun protein with psoriasis.
Doctor reviewing treatment with a patient
June 23rd 2021

Study: Alcohol Abuse Associated With Poor Therapeutic Response in Psoriasis

Jared Kaltwasser
Alcohol abuse, obesity, and the use of systemic therapies instead of biologics were all linked with poor response among individuals with psoriasis.
Systemic Therapies Linked With Herpes Zoster Risk in Patients With Psoriasis
June 16th 2021

Systemic Therapies Linked With Herpes Zoster Risk in Patients With Psoriasis

Jared Kaltwasser
Three biologics appeared to increase herpes zoster risk, but 2 other therapies were shown to lower the risk, according to a study of patients in a Taiwanese national database.
image of heart
June 11th 2021

Review: Patients With Psoriatic Arthritis Have Increased Rates of Metabolic Syndrome

Gianna Melillo
Results of a systematic review and meta-analysis point to higher rates of metabolic syndrome among patients with psoriatic arthritis.
Patient history form
May 29th 2021

Exploring the Common Characteristics in Psoriasis and Vitiligo

Allison Inserro
Both conditions involve a genetic predisposition as well as immune pathways that are triggered by environmental factors.
people graphic
May 26th 2021

A Look at Personalized Therapy for Psoriatic Arthritis

Larry Hanover
A review detailed the initial steps taken into personalized therapeutic options for psoriatic arthritis.
Psoriasis Recap: Investigational Therapies for GPP; How Patients View Remission in PsA
May 22nd 2021

Psoriasis Recap: Investigational Therapies for GPP; How Patients View Remission in PsA

AJMC Staff
Generalized pustular psoriasis (GPP) may have therapies in a few years; how patients define remission in psoriatic arthritis (PsA).
<1
...
67891011121314
...
16>

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo